SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-091371
Filing Date
2021-03-23
Accepted
2021-03-23 17:19:05
Documents
17
Period of Report
2021-03-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d103313d8k.htm   iXBRL 8-K 34756
2 EX-1.1 d103313dex11.htm EX-1.1 178817
3 EX-5.1 d103313dex51.htm EX-5.1 7313
4 EX-99.1 d103313dex991.htm EX-99.1 8865
5 EX-99.2 d103313dex992.htm EX-99.2 8971
9 GRAPHIC g103313g73c65.jpg GRAPHIC 3486
  Complete submission text file 0001193125-21-091371.txt   432050

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vrca-20210322.xsd EX-101.SCH 3066
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20210322_lab.xml EX-101.LAB 18887
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20210322_pre.xml EX-101.PRE 11857
10 EXTRACTED XBRL INSTANCE DOCUMENT d103313d8k_htm.xml XML 3456
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 21765666
SIC: 2834 Pharmaceutical Preparations